Citations 2
Clinical Characteristics Associated With High Baseline Glial Fibrillary Acidic Protein (GFAP) and Neurofilament Light Chain (NfL) Levels in Patients With Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD) From the
Wingerchuk, Dean M. , Kinoshita, Makoto , Allen, Kerstin , Bou-Chahine, Ruba, Parks, Becky , Stankowski, Jeannette N. , Bennett, Jeffrey L. , Nakahara, Jin , Seze, Jerome De , Clardy, Stacey , Pittock, Sean J.
Neurology | April 7, 2025 | Volume: 104 | Issue: 7_Supplement_1 | Pages: No page available
Evaluation of Glial Fibrillary Acidic Protein (GFAP) and Neurofilament Light Chain (NfL) Levels During Eculizumab and Ravulizumab Treatments in Aquaporin-4-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) (S32.004)
Wingerchuk, Dean M. , Kim, Ho Jin , Kinoshita, Makoto , Bou-Chahine, Ruba, Mashhoon, Yasmin, Parks, Becky , Allen, Kerstin , Thakar, Ketan, Carlin, Dan, Stankowski, Jeannette N. , Bennett, Jeffrey L. , Berthele, Achim , Clardy, Stacey , Nakahara, Jin , Seze, Jerome De , Pittock, Sean J.
Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available